GLOBEALERT
HEALTH● LOW1h ago · Oct 19, 2026, 11:15 PM

FDA Grants Accelerated Approval to Dostarlimab for dMMR Rectal Cancer

ajmc.com · United States · north america

The FDA has granted accelerated approval for Dostarlimab to treat dMMR rectal cancer, signifying a new treatment option for this condition.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More from United States

More in Health